IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of United Therapeutics Corporation

LOS ANGELES--()--Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against United Therapeutics Corporation (“United Therapeutics” or the “Company”) (Nasdaq: UTHR) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or by email at brian@lundinlawpc.com.

On July 27, 2017, United Therapeutics revealed that it recorded a $210 million accrual relating to a potential settlement in connection with a Department of Justice investigation into the Company’s possible violations of the Federal Anti-Kickback Statute and the Federal False Claims Act. Upon release of this information, shares of United Therapeutics fell in value.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contacts

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

Contacts

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/